Connect with us

Industry News

Biome Grow announces Memorandum of Understanding to purchase up to 20,000 kg per year of hemp-grown CBD extract from industrial hemp grower CBD Acres

Avatar

Published

on

default_cannabis_industry_cannamaps

TORONTO, Feb. 12, 2019 (GLOBE NEWSWIRE) — Biome Grow Inc. (“Biome” or the “Company”) (CSE: BIO) (Frankfurt: 6OTA) (OTCQB: BIOIF) today announced a Memorandum of Understanding (“MOU” or the “Agreement”) providing Biome with preferential access to a high quality and low cost supply of Cannabidiol (“CBD”) concentrate from CBD Acres Manufacturer Inc. (“CBD Acres”).
The MOU is for a period of five years pursuant to which Biome may acquire up to 20,000 kilograms per year of sun-grown, hemp-based CBD extract from CBD Acres using its unique Nano lipid, solventless extraction process. CBD Acres is founded by Canadian hemp farming pioneer, Mark Gobuty, who is also the founder of the Peace Naturals Project, Canada’s first Marijuana for Medical Purposes Regulations licensed cannabis grower.  CBD Acres is currently working with 4,500 acres of hemp farmland in Canada, including 1,000 acres of organic grow, which it expects to produce volumes that are equivalent to a 180 million square foot indoor cannabis production facility under the Canadian Cannabis Act.“Through this Agreement Biome is demonstrating a cannabis company can offer significant quantities of high-quality product at industry disrupting economics with a made in Canada product.  This can also be accomplished without spending substantial capital to build internal production facilities.  Moreover, Biome will now be in a position to supply both its domestic and international customers with affordable medicinal and therapeutic products based on CBD in the volumes that are required.”“CBD Acres is thrilled to have the visibility of a long-term partner for its bulk products business entering the market in the second half of 2019, and more importantly a strategic partner focused on commercialization in key medical-CBD markets, allowing CBD Acres to focus on growing and extraction innovation as well as its consumer products business,” said CBD Acres CEO Mark Gobuty.Biome is considered a “related party” to CBD Acres as such term is defined in Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (“MI 61-101”) on the basis that Jacob Capital Management Inc., a significant shareholder in the capital of the Company, is also a significant shareholder in the capital of CBD Acres. However, due to the service-type nature of the arrangement with no commitment or obligation for Biome to utilize the service provided by CBD Acres or to acquire an asset or assets from CBD Acres, the MOU is not considered to be a “related party transaction” as defined under MI 61-101.For further information, please contact:Alise Millsamills@sussex-strategy.com778-928-0267www.biomegrow.comAbout BiomeBiome wholly owns five subsidiaries, including: The Back Home Medical Cannabis Corporation, a company incorporated under the laws of the Province of Newfoundland and Labrador and in the late stages of applying for a license under the ACMPR; Great Lakes Cannabis, a company incorporated under the laws of the Province of Ontario and in the late stages of applying for a license under the ACMPR; Highland Grow Inc., a licensed producer in Nova Scotia under Canada’s ACMPR; Red Sands Craft Cannabis Co., a company incorporated under the laws of the Province of Prince Edward Island, and; Weed Virtual Retail Inc., a company incorporated under the laws of the Province of Ontario in the business of operating a new virtual reality technology platform focused exclusively on the medical and recreational cannabis markets. Biome is a Canadian-based company with national and international business interests.Forward-looking StatementsThis news release contains forward‐looking statements and forward‐looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward‐looking statements or information.  Generally, forward-looking statements and information may be identified by the use of forward-looking terminology such as “plans”, “ expects” or “does not expect”, “proposed”, “is expected”, “budgets”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases, or by the use of words or phrases which state that certain actions, events or results may, could, would, or might occur or be achieved. More particularly and without limitation, this news release contains forward‐looking statements and information concerning the MOU and the production of CBD by CBD Acres. Such forward-looking statements and information reflect management’s current beliefs and are based on assumptions made by and information currently available to Biome, including, among other things, assumptions and expectations with respect to: Biome making a determination to purchase services or acquire products pursuant to the MOU, CBD Acres’ ability to supply such services and products and Biome’s and CBD Acres’ ability to obtain and retain all necessary regulatory licenses, permits and approvals to produce and sell cannabis and generally operate its business.These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those expressed or implied in the forward-looking statements, including, among other things: a failure to obtain or delays in obtaining the required regulatory licenses, permits, or approvals; changes to legislation; changes in cannabis research or the general public’s perception of cannabis; crop failure; labour disputes; increases in labour and/or construction costs; rising energy costs; an inability to access financing as needed; and general economic downturn.Readers are further cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. The forward-looking statements speak only as of the date on which they are made, and Biome, or any of its subsidiaries undertakes no obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law. The forward-looking statements contained in this news release are expressly qualified by this cautionary statement.A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/1ee6840a-d821-420b-a67d-75a7f94e75e6

Original story can be found at: http://globenewswire.com/news-release/2019/02/12/1720473/0/en/Biome-Grow-announces-Memorandum-of-Understanding-to-purchase-up-to-20-000-kg-per-year-of-hemp-grown-CBD-extract-from-industrial-hemp-grower-CBD-Acres.html?f=22&fvtc=5&fvtv=41223728

Continue Reading

Industry News

Sugarmade Inc. Featured in CannabisNewsWire Publication Discussing Huge Impact of Hemp Industry on Farming

Avatar

Published

on

default_cannabis_industry_cannamaps

Original story can be found at: http://www.globenewswire.com/news-release/2019/08/23/1905984/0/en/Sugarmade-Inc-Featured-in-CannabisNewsWire-Publication-Discussing-Huge-Impact-of-Hemp-Industry-on-Farming.html?f=22&fvtc=5&fvtv=41223728

Continue Reading

Industry News

MariMed Receives Certificate of Occupancy for Cannabis Facility in New Bedford, Massachusetts

Avatar

Published

on

default_cannabis_industry_cannamaps

NORWOOD, Mass., Aug. 22, 2019 (GLOBE NEWSWIRE) — MariMed Inc. (OTCQX: MRMD), a premier cannabis and hemp multi-state operator focused on health and wellness, has received a certificate of occupancy from the city of New Bedford, Massachusetts for its new cannabis cultivation and manufacturing facility.
“ARL Healthcare, our Massachusetts cannabis licensed subsidiary, will now schedule its final state inspection to be cleared to commence full operations of its cultivation, production and dispensary,” said Bob Fireman, MariMed’s CEO. “The state inspection will also include our completed 10,000 sf dispensary located in Middleborough, Massachusetts.”The New Bedford manufacturing facility is part of a 137,000 sf building situated on 17 acres providing for future growth and expansion. This state-of-the-art cannabis production facility will open with 34,000 sf of canopy growing space, which will be processed in its GMP standard production laboratory and commercial kitchen. ARL Healthcare has already run local job fairs and commenced hiring and training some top individuals both in New Bedford and Middleborough, as part of its commitment to these municipalities. It intends to create over 100 new jobs in total in Massachusetts.MariMed will be introducing into the Massachusetts marketplace its top brands and products that have had great success in other state facilities under its management. This will include its flower brand Nature’s Heritage™ with its proprietary genetics and strains; its infused product brands Betty’s Eddies™, and Kalm Fusion™; and its exclusive licensed brands “The Healer,” “Binske,” “Tikun Olam,” “Lucid Moods,” “Dab Tabs” and others. These products will be made in the New Bedford facility and will be sold through company dispensaries as well as distributed to the wholesale market.“We are delighted to be entering into the Massachusetts market with its current shortage of supply,” noted Fireman. “ARL Healthcare is now a wholly owned subsidiary, as we work towards completing the consolidation of our managed licensed clients in multiple states. As such, the revenue from this operation will be reflected in our public company results.”ARL Healthcare under its RMD license, has three permits for dispensaries in Massachusetts. Middleborough will be first to open with the other two currently in the implementation process. The company intends to become one of the largest wholesale producers in Massachusetts to support both the medical and adult use markets and is positioned for great success in Massachusetts.About MariMedMariMed, a multi-state cannabis operator, is dedicated to improving the health and wellness of people through the use of cannabinoids and cannabis products. The company develops, owns and manages seed to sale state licensed cannabis facilities which are models of excellence in horticultural principles, cannabis cultivation, cannabis infused products and dispensary operations. MariMed has an experienced management team that has produced consistent growth and success for the company and its managed business units.The company is at the forefront of science and innovation through research developed by its lab technicians and medical advisors resulting in industry leading products and brands, including “Kalm Fusion” and “Betty’s Eddies.” These precision dosed products are focused on specific medical symptoms which are licensed and distributed across the country.In 2019, with the enactment of the 2018 US Farm Bill, MariMed formed MariMed Hemp, a wholly owned subsidiary, to leverage its seed to sale cannabis platform and experience into the emerging hemp-based CBD industry. The company acquired a significant stake in Kentucky-based GenCanna Global, a national and international leading cultivator, producer, and distributer of hemp and GMP quality CBD oils and isolates. With this strategic relationship, MariMed Hemp has developed and is marketing a portfolio of CBD brands and products to multiple retailers and direct to consumers both domestically and internationally. MariMed Hemp recently launched its Hemp Engine™ store-within-a-store distribution platform for retailers. It is also actively pursuing other hemp industry business opportunities with genetics, farming, biomass, and new and innovative technologies.For additional information, visit marimedinc.comFacebook: MariMedIncImportant Caution Regarding Forward Looking Statements
This release contains certain forward-looking statements and information relating to MariMed Inc. that is based on the beliefs of MariMed Inc.’s management, as well as assumptions made by and information currently available to the Company. Such statements reflect the current views of the Company with respect to future events including estimates and projections about its business based on certain assumptions of its management, including those described in this Release. These statements are not guarantees of future performance and involve risk and uncertainties that are difficult to predict, including, among other factors, changes in demand for the Company’s services and products, changes in the law and its enforcement and changes in the economic environment. Additional risk factors are included in the Company’s public filings with the SEC. Should one or more of these underlying assumptions prove incorrect, actual results may vary materially from those described herein as “hoped,” “anticipated,” “believed,” “planned, “estimated,” “preparing,” “potential,” “expected,” “looks” or words of a similar nature. The Company does not intend to update these forward-looking statements. None of the content of any of the websites referred to herein (even if a link is provided for your convenience) is incorporated into this release and the Company assumes no responsibility for any of such content.            
All trademarks and service marks are the property of their respective owners.Media & Investor Contact
Ronald Both or Jonathan Leuchs
CMA 
Tel (949) 432-7566
MRMD@cma.team
 

Original story can be found at: http://www.globenewswire.com/news-release/2019/08/22/1905643/0/en/MariMed-Receives-Certificate-of-Occupancy-for-Cannabis-Facility-in-New-Bedford-Massachusetts.html?f=22&fvtc=5&fvtv=41223728

Continue Reading

Industry News

CO Gov Polis charts course for CBD and hemp innovation at sold-out AHPA Supplement Congress

Avatar

Published

on

default_cannabis_industry_cannamaps

Denver, CO, Aug. 22, 2019 (GLOBE NEWSWIRE) —Colorado Governor Jared Polis rallied more than 200 hemp farmers, manufacturers, producers, retailers, and industry professionals during his keynote address to the American Herbal Products Association (AHPA) Hemp-CBD (cannabidiol) Supplement Congress held earlier this month.No stranger to CBD and hemp legislation, Polis called for action for an easier hemp licensing application process, which he says would strengthen agricultural communities.“We know what’s worked to grow our agricultural sectors, and it’s no different for hemp. It’s a big part of our rural economic initiative,” Polis said. “You came to the right place to learn about an industry that is very much, even in Colorado, still in our early days, but more mature than in other states.”Colorado is on the forefront of industrial hemp production thanks to innovative leadership and Polis outlined the newest public-private initiative called CHAMP (Colorado Hemp Advancement and Management Plan). The plan was created to provide in-depth knowledge and information about CBD to other governmental agencies. CHAMP consists of eight focus groups and concentrates on research, development and seed; cultivation; testing; transportation; processing; manufacturing; marketing; banking and insurance. Food and Drug Administration (FDA) and U.S. Department of Agriculture (USDA) officials also provided an update on efforts to implement hemp provisions in the 2018 Farm Bill.Cara Welch, FDA’s Acting Special Assistant to the Deputy Commissioner for Policy Legislation & International Affairs, stressed that the agency has well-established frameworks and regulatory tools for evaluating products under its jurisdiction and the same frameworks and tools are being applied to hemp.“We’re trying to be as transparent and informative as possible on these issues, and to resolve open questions quickly, efficiently, but also thoughtfully,” Welch said. USDA Hemp Program Chief Bill Richmond said that federal authorities are working to provide farmers and state and local regulators with a solution that simplifies interstate hemp commerce and the USDA is wrestling with the Farm Bill’s requirement for a national THC testing protocol.“Our goal is to provide a consistent, easy-to-follow regulatory framework around hemp production,” Richmond said.During the two-day AHPA Congress, hemp industry experts shared preliminary data showing rapid industry growth. Hemp-derived CBD sales ballooned to $238 million, an increase of 57% in 2018 over the previous year, according to Nutrition Business Journal. Hemp acreage under license across the U.S. increased nearly five-fold in the past year from 112,000 acres in 2018 to 480,000 acres in 2019, according to data gathered by advocacy group votehemp.com.“The overwhelming turnout for the first AHPA Hemp-CBD Supplement Congress demonstrates this emerging industry’s commitment to becoming a well-regulated industry in order to meet growing consumer demand for legal, safe and high-quality products,” said AHPA President Michael McGuffin. “The industry must navigate rapidly evolving legal, regulatory and financial landscapes and AHPA is taking what it has learned from the well-established herbal industry to provide companies with the expertise and resources needed to ensure the long-term success of this emerging sector of the herbal industry.”More than 100 attendees also participated in half-day workshops covering current good manufacturing practice (cGMP) requirements for dietary supplements and regulations for new dietary ingredients (NDIs) and generally recognized as safe (GRAS) ingredients for food and supplements.Additional HighlightsGetting to market and hemp supply chain managementA primer on FDA regulation of hemp-CBD supplementsHemp-CBD supplements from the retailers’ perspectiveMedia Coverage Colorado Biz Magazine, August 19, 2019: https://www.cobizmag.com/Trends/Governor-Polis-Establishes-Way-Forward-for-Colorado-Hemp-Industry/Westword, August 17, 2019: https://www.westword.com/marijuana/governor-jared-polis-outlines-colorados-hemp-strategy-11450725NUTRAingredients-USA, August 19, 2019: https://t.co/hegIjedPXW?amp=1 NUTRAingredients-USA, August 20, 2019: https://www.nutraingredients-usa.com/Article/2019/08/20/Brand-development-key-to-success-in-CBD-game###About AHPAThe American Herbal Products Association (AHPA) is the national trade association and voice of the herbal products industry. AHPA is comprised of more than 400 member companies, consisting primarily of domestic and foreign companies doing business as growers, processors, manufacturers and marketers of herbs and herbal products as foods, dietary supplements, cosmetics, and non-prescription drugs, and also including companies that provide expert services to the herbal trade. Founded in 1982, AHPA’s mission is to promote the responsible commerce of herbal products to ensure that consumers continue to enjoy informed access to a wide variety of herbal goods. www.AHPA.org
Attachmentsimage2pixilstudio-events2-286Haley Chitty
American Herbal Products Association (AHPA)
3015881171 ext. 104
communications@ahpa.org

Original story can be found at: http://www.globenewswire.com/news-release/2019/08/22/1905542/0/en/CO-Gov-Polis-charts-course-for-CBD-and-hemp-innovation-at-sold-out-AHPA-Supplement-Congress.html?f=22&fvtc=5&fvtv=41223728

Continue Reading

Trending